Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Venlafaxine Hydrochloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 84Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Viatris Reports Positive Results From Phase 3 Study In Japan
    Viatris Reports Positive Results From Phase 3 Study In Japan

    09 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/viatris-announces-positive-top-line-results-from-phase-3-study-of-effexor-in-japanese-adults-with-generalized-anxiety-disorder-gad-302270664.html

    PR NEWSWIRE
    09 Oct 2024
    Share Share
    Enforcement Report - Week of July 31, 2024
    Enforcement Report - Week of July 31, 2024

    31 Jul 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-31-2024-99481.pdf

    FDA
    31 Jul 2024
    Share Share
    Alembic's Generic Venlafaxine Hydrochloride Receives Approval in US
    Alembic's Generic Venlafaxine Hydrochloride Receives Approval in US

    06 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217767

    FDA
    06 Jun 2024
    Share Share
    Nostrum's Generic Venlafaxine Hydrochloride Receives Approval in the U.S.
    Nostrum's Generic Venlafaxine Hydrochloride Receives Approval in the U.S.

    04 Apr 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200430

    FDA
    04 Apr 2023
    Share Share
    Mankind's Generic Venlafaxine Hydrochloride Receives Approval in the U.S.
    Mankind's Generic Venlafaxine Hydrochloride Receives Approval in the U.S.

    28 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216044

    FDA
    28 Nov 2022
    Share Share
    US FDA approves Venlafaxine Extended-Release Tablets and Pregabalin
    US FDA approves Venlafaxine Extended-Release Tablets and Pregabalin

    06 Sep 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/us-fda-approves-venlafaxine-extended-release-tablets-and-pregabalin-extended-release-tablets-by-zydus/

    EXPRESS PHARMA
    06 Sep 2022
    Share Share